India Markets closed

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
55.51+1.24 (+2.28%)
At close: 4:00PM EDT

55.32 -0.19 (-0.34%)
After hours: 7:52PM EDT

Full screen
Trade prices are not sourced from all markets
Previous close54.27
Open54.20
Bid55.32 x 800
Ask55.93 x 1800
Day's range54.02 - 55.84
52-week range36.15 - 64.94
Volume4,955,818
Avg. volume6,475,801
Market cap146.334B
Beta (5Y monthly)0.21
PE ratio (TTM)67.82
EPS (TTM)0.82
Earnings dateN/A
Forward dividend & yield1.40 (2.58%)
Ex-dividend date13-Aug-2020
1y target est59.10
  • Canada's biggest provinces seek clampdown on social gatherings as coronavirus cases top 150,000
    Reuters

    Canada's biggest provinces seek clampdown on social gatherings as coronavirus cases top 150,000

    Canada's two most populous provinces on Friday moved to clamp down further on social gatherings in a bid to slow a second wave of coronavirus infections that since the start of the pandemic now total more than 150,000 nationwide. Premier Doug Ford, whose government has already slashed the size of permitted gatherings indoor and outdoors, repeated his concerns that the majority of new cases were in people under 40. Health officials in Canada have been making increasingly gloomy comments in recent days.

  • Exclusive: AstraZeneca gets partial immunity in low-cost EU vaccine deal
    Reuters

    Exclusive: AstraZeneca gets partial immunity in low-cost EU vaccine deal

    European governments will pay claims above an agreed limit against AstraZeneca over side-effects from its potential COVID-19 vaccine, under different terms to a deal struck with Sanofi, an EU official told Reuters. AstraZeneca has secured the European Union's backing in a confidential agreement which reflects the lower price sought by the British drugmaker, the official said. Unexpected side-effects after a drug has regulatory approval are rare, but the speed at which a COVID-19 vaccine is being pursued increases the risks of unforeseen conditions.

  • Coronavirus update: Trump suggests he may overrule FDA vaccine approval; airlines ramp up testing
    Yahoo Finance

    Coronavirus update: Trump suggests he may overrule FDA vaccine approval; airlines ramp up testing

    President Donald Trump has fanned new concerns over the politicization of coronavirus vaccine approvals, suggesting he could block stricter guidance from the FDA.